5/2/2013

The FDA has cleared NovoSource to market its NovoKnee system, which is tailored for use by
orthopedic doctors in performing total joint replacement surgeries for the knee. The device is meant to provide a lower-cost implant and cut medical expenses for orthopedic patients.

Related Summaries